Pelthos Therapeutics Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pelthos Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2026-03-31 was $668.00K, a 1184.62% increase year-over-year.
- Pelthos Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-09-30 was $811.00K, a 1830.95% increase year-over-year.
- Pelthos Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-06-30 was $52.00K, a 271.43% increase year-over-year.
- Pelthos Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-03-31 was $52.00K.
- Pelthos Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2025 was $1.51M, a 1335.24% increase from fiscal 2024.
- Pelthos Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2024 was $105.00K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2026-03-31 | $668.00K 10-Q/A · filed 2026-08-13 | |
| 2025-12-31 | $1.51M 10-K · filed 2026-03-19 | |
| 2025-09-30 | $811.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $52.00K 10-Q · filed 2025-11-13 | |
| 2025-03-31 | $52.00K 10-Q/A · filed 2026-08-13 | |
| 2024-12-31 | $105.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $42.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $14.00K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |